Mylan launches first trastuzumab biosimilar, Hertraz, in India
Is indicated for the treatment of HER2-positive metastatic breast cancer and is available in two strengths
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Latest Updates
USP and Indian Pharmacopoeia Commission to host 13th Science &Standards Symposium
To focus on global standards for medicines
ICONIC 2014 discusses prevention and control measures of COPD
Jointly hosted by Chest Research Foundation (CRF) and Johns Hopkins Bloomberg School of Public Health, USA, the first conference…
Agilent Technologies introduces new version of Intelligent System Emulation Technology
SET Enables Emulation of Waters Acquity UPLC, Shimadzu Prominence HPLC Agilent Technologies Inc. (NYSE: A) today introduced the…
Gilead names Mylan as exclusive branded medicines business partner for India
Under the agreement, Mylan will market and distribute in India certain Gilead medications
Bayer CropScience, India appoints Richard van der Merwe as Managing Director
In addition, he will be the Bayer Representative for South Asia, based in Mumbai
Buyouts to increase in consumer, pharma, tech sectors in 2014: KPMG’s M&A Predictor
As Indian economy shows signs of bottoming out, analysts expect 2014 to be a much better year with increased M&A sentiment …
Phenomenex releases Updated Product Guide for 2014/2015
New guide is available online or in a full-colour print version
Waters expands UNIFI solutions with three new applications: glycans, forensic toxicology and natural…
Waters now offers eight UNIFI-based solutions based on the premier multi-user, server-based technology for management of…
Multisorb Technologies appoints Paige Weis to HealthCare Packaging Group
Will be responsible primarily for providing sales and service support to the diagnostic market in North America
Venus Remedies bags US patent for Achnil
Developed by Venus Medicine Research Centre it will be commercialised in US market through technology transfer/outlicensing of…
Results of independent clinical validation study of Almac-developed ColDx assay presented at ASCO-GI
Data shows assay to be a significant predictor of risk of recurrence in stage II colon cancer
Syrris Atlas has the Midas touch with nanoparticles
Midatech is a clinical stage biotechnology company
BIOINVEST 2014 concludes successfully boosting investor confidence
BIOINVEST 2014 addressed the critical barriers in the biotech industry
Glenmark’s consolidated revenue increases by 15.92 per cent in Q3 FY 13-14
Net profit for the third quarter was Rs 2162.36 million as compared to Rs 2129.17 million for the previous corresponding quarter